Michelle LaSpaluto, the Chief Financial Officer of Chimerix Inc . (NASDAQ:CMRX), has recently sold 2,260 shares of the company's common stock, according to a regulatory filing. The transaction comes ...
In a recent transaction, Allen S. Melemed, the Chief Medical (TASE:PMCN) Officer of Chimerix Inc . (NASDAQ:CMRX), sold 3,065 shares of the company's common stock. The shares were sold at an average ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback